Pharma Reviews: Advent can deploy $1.7 bn in India in 3-5 years: Chairman

Additionally, we see an improvement in the exit market in terms of .... Indian pharma companies are battling both regulatory as well as pricing ...
Read more: Advent can deploy $1.7 bn in India in 3-5 years: Chairman